bullish
Prodia (PRDA IJ) - Back to Core Testing
457 Views31 Mar 2023 07:49
Prodia (PRDA IJ) FY2022 results saw declines in revenues and profits but from a COVID-high base and the numbers are now well-above 2019, with strong prospects ahead.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
- The Week That Was in ASEAN@Smartkarma - Prodia Diagnosed, Bukalapak, and MAPI's Omnichannel08 May 2023
- Prodia (PRDA IJ) - Shaking off the COVID Factor05 May 2023
- The Week the Was in ASEAN@Smartkarma - Mitra Adiperkasa, Bukalapak, and Singapore Airlines03 Apr 2023
- Prodia (PRDA IJ) - Back to Core Testing31 Mar 2023
- Prodia (PRDA IJ) - A Standout in Diagnostics14 Nov 2022
- Prodia (PRDA IJ) - Injecting Digital Health28 Sep 2022
- Prodia (PRDA IJ) - Diagnosed for Growth27 Mar 2022
x